Will Semaglutide Make You Lose Muscle?

Yes, some of the weight you lose on semaglutide is muscle. That is the honest, uncomfortable headline — but it comes with a much more important second sentence: this is not a strange or unique property of the drug. Losing some lean mass alongside fat is what happens during almost any substantial weight loss, whether you get there through dieting, bariatric surgery, or a GLP-1 medication. The question worth asking is not "does semaglutide cause muscle loss?" (everything that makes you lose weight does, to some degree) but "is the muscle loss on semaglutide worse than expected, and what can I actually do about it?" On both counts the evidence is more reassuring — and more actionable — than the alarming headlines suggest.

What the body-composition data actually show

When researchers measure body composition with DXA or MRI scans during weight loss, they consistently find that a meaningful slice of the total is fat-free (lean) mass rather than fat. The most recent and rigorous numbers come from meta-analyses of randomized trials.

A 2026 systematic review and meta-analysis of 20 randomized trials (nearly 16,000 participants) put hard figures on it: lean mass made up 25–39% of total weight lost across incretin therapies, with semaglutide specifically at about 35% and tirzepatide lower at about 25%¹. A separate network meta-analysis of 22 trials reached a compatible conclusion — GLP-1 receptor agonists reduced lean mass by roughly 0.86 kg on average, about 25% of total weight lost — but added a crucial nuance: the relative lean mass (lean tissue as a percentage of body weight) did not actually fall, because you are losing both fat and lean tissue while ending up a smaller person overall². In plain terms, you can lose absolute pounds of muscle while your body composition stays proportionally similar or even improves.

The single most important comparison: drug vs diet

Here is the finding that should reframe the whole conversation. That same 2026 meta-analysis directly compared incretin drugs against intensive lifestyle (diet) weight loss — and found the proportion of weight lost as lean mass was broadly comparable between them (around 26% for lifestyle, statistically indistinguishable from the drugs)¹. In other words, semaglutide is not stripping muscle in some uniquely dangerous way; it is producing the ordinary lean-mass loss that accompanies any large, rapid weight reduction. The drug is just very good at producing large, rapid weight reduction, so the absolute amount of lean tissue lost can be larger simply because the total loss is larger.

There is one important asterisk. Because GLP-1 drugs work partly by suppressing appetite, it is easy to undereat protein and to lose weight without doing any resistance exercise — and both of those omissions worsen muscle loss. So the practical risk on semaglutide is less about the molecule and more about the behavior it makes easy: eating very little, of whatever is convenient, and not lifting anything. That is also the lever you control. (This is exactly why stacking a restrictive fasting window on top of the drug is risky — see semaglutide and intermittent fasting.)

Why losing muscle matters (and why it's not a reason to skip treatment)

Muscle is not just aesthetic. Skeletal muscle drives resting metabolism, supports glucose handling, and underpins strength, balance, and independence — which matters especially for older adults, in whom excessive lean-mass loss can tip toward sarcopenia. So preserving muscle during weight loss is a genuine clinical goal, not vanity.

But the conclusion is emphatically not "avoid semaglutide to protect your muscle." For most people with obesity, the metabolic and cardiovascular gains of meaningful weight loss outweigh the lean-mass cost, particularly when the loss of fat mass — including dangerous visceral fat — is far larger than the loss of lean mass. The same meta-analyses that flag lean-mass loss show fat mass falling two to three times more than lean mass². The right response is to mitigate the muscle loss, not forgo the treatment.

What actually preserves muscle: the two evidence-backed levers

Two interventions have solid randomized-trial support for protecting lean mass during weight loss, and both are things you do, not drugs you add.

1. Eat enough protein. Higher protein intake during an energy deficit consistently preserves more lean mass than lower protein. In a randomized trial, a higher-protein diet combined with exercise during a calorie deficit produced greater lean-mass retention (and even gain) and more fat loss than a lower-protein diet³. The practical target most clinicians and sports-nutrition reviews land on during active weight loss is roughly 1.2–1.6 g of protein per kg of body weight per day⁴ — which is genuinely hard to hit when a GLP-1 drug has cut your appetite, so it takes deliberate planning. Our protein on semaglutide guide breaks the target down by body weight and per meal, and our what to eat on Wegovy guide is built around getting protein in despite a small appetite.

2. Do resistance training. This is the most powerful single lever. The 2026 meta-analysis found that lifestyle weight loss plus resistance training had by far the most favorable body-composition profile — lean mass made up only about 17.5% of total weight lost, well below the ~25–35% seen without it¹. A dedicated meta-analysis of resistance exercise during dietary weight loss confirms it preserves muscle mass and strength and improves cardiometabolic health compared with dieting alone⁵. You do not need to become a bodybuilder; two to three sessions a week of progressive resistance work is the evidence-backed dose.

Combine the two — adequate protein and resistance training — and you shift the entire equation. The muscle loss that looks scary in a headline becomes a manageable, largely preventable side of the ledger.

The honest bottom line

Semaglutide does cause some muscle loss — roughly a quarter to a third of total weight lost shows up as lean mass in trials — but this is fundamentally a feature of rapid weight loss itself, not a toxic effect unique to the drug, and the proportion is broadly the same as you would see losing the same weight by dieting¹². Your relative body composition often holds or improves because fat loss far outpaces lean loss. The muscle loss is real but largely modifiable: prioritize protein (about 1.2–1.6 g/kg/day) and lift weights two to three times a week, and you can preserve the lean tissue that matters³⁵. For the full evidence picture on what semaglutide does, start with our pillar, Semaglutide: how it works, results and side effects; if you are timing your expectations, when does Wegovy start working? maps the curve, and our best semaglutide providers guide covers where to get treatment.